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ABSTRACT 
Reducing the number of animal subjects used in biomedical experiments is desirable for both 
ethical and practical reasons. Previous suggestions for reducing sample sizes in these experiments 
have focused on improving experimental designs and methods of statistical analysis; reducing the 
number of controls (thus, the number of overall animals used) is rarely mentioned. We discuss 
how the number of current control animals can be reduced, without loss of statistical power, by 
incorporating information from historical controls, i.e. animals used as controls in similar 
previous experiments. Using example data from the literature, we describe how to incorporate 
information from historical controls under a range of assumptions, implemented either as familiar 
t-tests, contrasts, or in a mixed models context. Assuming more similarities between historical
and current controls yields higher savings and allows the use of smaller current control groups.
We conducted simulations, based on typical designs and sample sizes, to quantify how different
assumptions about historical controls affect the power of statistical tests. Under our simulation
conditions, the number of current control subjects can be reduced by more than half by including
historical controls in the analyses. Paying attention to both the function and to the statistical
requirements of control groups would result in reducing the total number of animals used in
experiments, saving time, effort and money, and bringing research using animals within ethically
acceptable bounds.
Key words: animal testing, animal welfare, borrowing information, control group, reduction, 
sample size, statistical power, three Rs. 
1. Introduction
Although precise figures are lacking, a great majority of basic and pre-clinical biomedical 
research is conducted using laboratory animals, particularly mice and rats. Research with animals 
must comply with ethical guidelines that require, among other things, that researchers use the 
minimal number of animals necessary to achieve a scientific goal. Reducing the number of 
animals used in experiments is desirable for both ethical and practical reasons but must be based 
on a rational optimization process (i.e. pilot studies, formal power analyses) rather than tradition 
or prevailing constraints. One way to reduce the number of animals in an experiment is to reduce 
the size of current control groups. Here we demonstrate several strategies for incorporating 
information from historical controls, and, by so doing, reduce the number of current controls 
needed. Historical controls have been considered an undesirable option (Altman & Bland, 1999; 
100




Keenan et al., 2009; Neuenschwander et al., 2010), particularly when the historical information is 
obtained from sources external to the laboratory conducting the research (Food and Drug 
Administration, 2001). This is because known or unknown biases can differentially affect 
subjects in the various control groups when all subjects are not drawn contemporaneously from 
the same population. However, we show that, judiciously used (and the keyword here is 
'judiciously', as explained below), historical controls improve the researcher’s ability to detect 
treatment effects and provide a useful tool for reducing the number of animals used as controls. 
The focus of this paper is to provide a framework, largely in the mixed-models paradigm, 
to reduce the number of control animals needed in biomedical experiments without 
compromising the ability to detect a statistically significant treatment effect. We believe that the 
approaches and arguments outlined here will provide a valuable aid for researchers and contribute 
to alleviating the ethical burden of performing experiments with animals. 
2. Controls
Researchers may be uncertain about what the right controls are for a given experiment or whether 
they are really needed. This is not surprising as conventional statistics textbooks used by 
biologists typically have little discussion on controls, neither their purposes nor how to integrate 
them into the experimental design. When mentioned, the advice is to consider them as another 
treatment group. Unfortunately, neither researchers nor their consulting statisticians receive 
adequate training on how best to incorporate controls into experiments, often each believing that 
the other has the expertise. 
The various types of controls used in experiments are explained clearly in Johnson & 
Besselsen (2002). They categorize controls as positive, negative, sham, vehicle (to test, e.g. the 
delivery system of a drug by itself), and comparative (positive control with a known treatment). 
In a negative control, control subjects remain in the ‘normal’ pre-experimental state; no change is 
expected from the pre-experimental to experimental condition. In a positive control, subjects 
receive some kind of pre-treatment (e.g. a toxin, a lesion) that is expected to cause a change from 
the pre-experimental state. The researcher can then see if a treatment (e.g. a vaccine) is effective 
by comparing treated subjects with subjects that do not receive a treatment. The positive control 
guards against miraculous recoveries, the negative against spontaneous disease and death. Sham 
controls are subjected to a manipulation that mimics the procedure received by positive controls 
and treated animals, but nothing else. Placebo controls often are considered negative controls in 
some clinical trials, but are more correctly a type of sham control. In fact, labeling controls as 
‘positive’, ‘negative’, etc., may not provide much clarity. Often a short explanation is better than 
a label. It is important to understand what the purpose of the control is and whether it is the right 
kind of control for the experiment; some experiments may require several kinds of controls.
How many control subjects are needed in an experiment? This should depend on 
knowledge gained from the results of prior experiments. The cumulative knowledge in the field 
provides historical information that can be put to good use to reduce the number of animals in 
current control groups. The Bayesian statistical framework formally includes prior information 
when estimating a statistical model (e.g. French, Thomas & Wang, 2012). However, biomedical 
research typically does not take advantage of this: most researchers conducting biomedical 
experiments on animals continue to use ‘classical’ Fisherian statistics (Efron, 2013), and there is 
little published guidance on how to incorporate information from prior experiments (Pocock, 
1976; Neuenschwander et al., 2010; Viele et al., 2014). Since controls are included in most 
experiments, in the typical experiment we actually know far more about the control group than 
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about the treatment group, either through experience with controls in similar experiments or 
through the literature (Schulz & Grimes, 2005). However, we ignore this prior knowledge when 
we analyze the results of an experiment carrying out a classical statistical analysis, like a t-test or 
analysis of variance (ANOVA) using only animals involved in the current experiment. A 
laboratory performing similar experiments over many years will be far more sensitive to controls 
responding in unanticipated ways than to peculiar responses of treatment groups. Why not 
incorporate this prior knowledge? 
Controls can be current or historical. Current or concurrent controls are contemporaneous 
with the treatment group(s), whereas historical, retrospective or background controls are obtained 
from prior experiments where similar protocols were applied to controls. Although the use of 
historical controls has been widely discussed in the literature, many researchers are unaware of 
their potential usefulness or do not know how to incorporate them into their experimental 
designs. In fact, the use of historical controls in biomedical research appears restricted to some 
areas of toxicology and to certain kinds of clinical trials involving humans. In these types of 
research, the dependent variable is usually a proportion (dichotomous or binary outcomes), and 
historical controls may not come from the same laboratory, potentially introducing an additional 
source of variation, often termed ‘laboratory bias’.  
A basic concern about using these historical controls is whether it is valid to test if the 
proportion from a current treated group differs from that of a historical control. The answer 
depends on whether historical controls provide a good estimate for what one would have obtained 
had one used current controls, and how one handles the data statistically. These various 
possibilities have been laid out in a Bayesian context by Spiegelhalter, Abrams & Myles (2004) 
and Viele et al. (2014); they range from ignoring current controls (i.e. use only information from 
historical controls) to ignoring historical controls (traditional analysis). For quantitative data 
where normal distribution theory can be applied, there are additional options for using historical 
data, as discussed below.  Thus, a basic difference between the previously suggested use of 
historic controls in clinical trials (using humans) and our suggested use for biomedical 
experiments (using animals) is that historical controls in clinical trials typically come from 
different laboratories, where critics can, with some justification, complain about difficult to 
quantify laboratory biases. Instead, we advocate borrowing historical control information only 
when there is a reasonable expectation of no laboratory biases (see below). 
Historical controls can be used to better estimate parameters related to the current 
experiment under a variety of assumptions. Under the strongest assumption, if one has a large 
number of historical controls and one assumes that they are stable, i.e. neither the mean nor the 
variance of the historical controls change over experiments, then one can consider the historical 
control mean and variance to be fixed and only the current control and treatment groups have 
sampling error uncertainty. In this case, the need for a current control is debatable (other than to 
monitor laboratory conditions or to increase the number of historical controls available for future 
experiments). One has only to decide whether the treatment group mean and variance need to be 
estimated or just the mean, i.e. assume that the historical control groups provide a better estimate 
of the true within-group variance. This essentially is the framework used in the literature for 
conditional tests (conditional on the control group parameters considered as constants); the 
interest here is in differences of rates (proportions) (e.g. Yanagawa & Hoel, 1985; Yoshimura & 
Matsumoto, 1994). This use of historical controls can result in substantial reduction in 
experimental animal use. According to Browne (1976), for a given power and significance level, 
the estimated sample sizes are between one-quarter and one-half those needed if no historical 
controls are used (but see Lee & Tseng, 2001).  
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A less stringent assumption holds that there is only sampling variability in both historical 
and current controls, and that all controls vary about the same mean. In that case historical and 
current control data can be pooled, i.e. these observations are exchangeable, giving a larger 
sample size to estimate the control mean. If this model is not considered appropriate, models with 
fewer assumptions can be used, e.g. to allow for random experiment-to-experiment variation by 
including a random effect for experiments, or for treatments and controls to have different 
variances; in these cases the observations are not exchangeable. The analysis is then done in the 
mixed-models framework, which makes it possible to ‘borrow’ information from previous 
experiments on both means and variances. This is a kind of ‘dynamic’ borrowing of information, 
the amount of borrowing dictated by the quantity and characteristics of historical control data 
(Viele et al., 2014). A related approach, that we do not consider further, is subjectively 
discounting but not completely ignoring historical control data, as explained in Spiegelhalter et 
al. (2004). 
A further relaxing of assumptions entails use of historical controls only to estimate 
variances since larger sample sizes are needed to estimate variances than means, and to use the 
current control group only for estimating the control mean, i.e. borrowing information across 
experiments only for variance estimation. This will reduce the number of animals compared to 
using data only from the current experiment but not as much as for the stronger assumptions 
discussed above. Here the gain one obtains is largely due to the increased residual degrees of 
freedom involved in the contrast between the current control group and the treatment groups.  
In this paper we first describe how to incorporate (i.e. borrow) information from historical 
controls under different sets of assumptions using data from a series of nutrition experiments with 
rats. We then use simulations to demonstrate potential savings from using historical controls and 
to illustrate a few other points. We also provide suggestions about the use of historical controls 
for quantitative and proportion data.  
3. Experimental data
Our exemplary data are haemoglobin concentrations (g/100 ml), measured using an electronic 
cell counter, of Sprague–Dawley rats in a series of copper-deficiency experiments run over 
several years (Fig. 1; data from Reeves & DeMars, 2004; Reeves et al., 2005; Saari et al., 2006; 
Relling et al., 2007; Johnson & Johnson, 2009). There were eight groups of control rats available 
for our analysis, with various numbers of individuals per group. As can be seen in Fig. 1, means 
of these controls varied among the groups (13.3–15.0); we chose the control group with the 
highest mean to act as the current ‘treatment’ group (G.t in Fig. 1) and one of the two groups with 
five observations to act as the current ‘control’ group (G.c in Fig. 1). While every data set is 
unique, these data were chosen because they appear to be fairly typical of control measurements 
collected over several years on a laboratory animal, thus are ‘real data’, even if group labeling is 
contrived. 
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Figure 1. Haemoglobin concentrations (g/100 ml) for control rats in eight nutrition 
experiments used to illustrate how different assumptions about incorporating historical 
controls in statistical testing affects outcomes. The historical controls are named A.c - F.c. 
In the current experiment, G.c is the control group and G.t the treatment group (rats in the 
G.t group were actually controls in the original experiment, but had the highest mean
among the control groups, so we use them as the current ‘treatment’ group for illustrative
purposes).
We tested for a difference between a treatment group and controls using a variety of 
statistical models with assumptions corresponding to those outlined above (Table 1; see Table 2 
for underlying statistical models and Fig. 2 for illustrative examples). We abbreviate "assumption 
set" as "AS" here and elsewhere in this paper. These AS’s determine how much information we 
can borrow from historical controls, that is, how much we allow parameter estimates from 
historical controls to influence parameter estimates from current controls. Models, in decreasing 
order of borrowing information, are as follows.  
(AS 1) Many historical controls are available and we can consider controls to have a fixed mean; 
use a one-sample t-test to determine if the treatment mean differs from a constant (the control 
mean); our exemplary data are not consistent with these assumptions. 
(AS 2) Assume that controls are stable and pool current and historical controls; use a two-sample 
t-test or ANOVA to test if the treatment group mean differs from that of the pooled control mean;
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exemplary data are not consistent with these assumptions.  
(AS 3) Assume that historical controls are relatively stable but allow for an experiment-to-
experiment random effect, i.e. the current control and treatment group comprise one block; fit a 
linear mixed model, with experiment as a random effect, and two levels of the treatment factor 
(treated versus control), this contrasts the adjusted treatment mean to the overall adjusted control 
mean; exemplary data are consistent with these assumptions.  
(AS 4) Same as (AS 3) but allow the treatment group to have a different within-group variance 
than control groups; fit a linear mixed model as above, with control groups all sharing one 
within-group variance and estimate a different within-treatment group variance; this model is 
over-parameterized for our exemplary data.  
(AS 5) Assume that historical control means are not sufficiently stable to use for comparison, and 
within-control group variances are stable but they differ from the treatment variance, allow for an 
experiment-to-experiment random effect; use the same linear mixed model as (AS 4) but create a 
1 d.f. contrast between the current treatment and control groups; over-parameterized for our 
exemplary data.  
(AS 6) Same as (AS 5) except model as a typical ANOVA so all groups share a common within-
group variance; fit a linear model with each group as a factor level, create a 1 d.f. contrast 
between the current treatment and current control groups; over-parameterized for exemplary data. 
(AS 7) Assume that historical control groups are not useful; test only current controls against the 
treatment group using a t-test or ANOVA. This is the typical assumption in most research 
laboratories where potentially useful information from historical controls is ignored; exemplary 
historical data ignored.  
Results under the various assumptions follow, in reverse order.  AS 7: if only current 
groups are compared (G.c versus G.t), the P value from an ANOVA (1, 13 d.f.) on an estimate of 
the difference between means of 0.85 (S.E. = 0.47) is 0.094.  AS 6 & 5: if an ANOVA is applied 
to the whole data set and an a priori contrast between G.c and G.t made, with 82 d.f., the estimate 
is still 0.85, but the S.E. is now 0.42 and the P value 0.047. We have borrowed information from 
other control groups, so have a better estimate of the ‘true’ S.E. for the contrast, and have more 
degrees of freedom to test it. The same results are obtained if we model the factor, experiment, as 
a random effect, with the experiment-to-experiment variance estimated to be 0.328.  AS 4 & 3: if 
we assume for these exemplary data that all control groups share an underlying true common 
mean but there is a random experiment-to-experiment effect, the treatment–control difference is 
estimated as 0.99 (S.E. = 0.37) with a P value of 0.010; we get similar results assuming unequal 
variances.  AS 2: if we had simply pooled over controls, the treatment–control difference is 1.22 
and, using ANOVA, the P value is 0.0001 on 1 and 88 d.f.  AS 1: if we test the treatment group 
against a constant control mean (= 13.79 over all controls, difference with treatment group = 
1.22) using a t-test, on 9 d.f., the P value = 0.0002.  
As stronger assumptions are made, P values decrease and therefore, our ability to detect a 
statistically significant treatment effect increases. However, even for AS 6 & 5, there is a benefit 
to including the historical controls; fewer concurrent controls are needed to achieve the same 
power if historical controls are included. 
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Table 1. Summary of assumption sets regarding historical controls. 
Assumptions Assumption set 






























T & C 
can 
differ 







See text for description of assumption sets. 
HC, historical control groups; NA, not applicable; T & C, treatment and control groups. 
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Table 2. Models and tests for assumption sets. 
AS Model for mean Model for variance structure Test 






, 𝜇𝑐 fixed 















3 𝑦𝑖 = 𝜇𝑗 + 𝛾𝑙; 
 𝑗 = 𝑡, 𝑐1, 𝑐2, … , 𝑐𝑘; 
 𝑙 = 1, 2, … , 𝑘 
Each block (treatment or control 






observations from 𝑗 = 𝑡, 𝑐1 are in 
block 𝑙 = 1; each historical control 
group forms its own block, 𝜌 is an 
estimated within-block covariance, it 




, where 𝒂 







, … )′, 𝑿  is 
the design matrix, and ?̂?  
is the estimated variance-
covariance matrix for the 
𝑦𝑖 observations. 
4 𝑦𝑖 = 𝜇𝑗 + 𝛾𝑙; 
 𝑗 = 𝑡, 𝑐1, 𝑐2, … , 𝑐𝑘; 
 𝑙 = 1, 2, … , 𝑘 
Historical control groups as for AS 3, 
















where variances of observations of the 
treatment group differ from those of 
current and historical controls. 
Same as AS 3 except ?̂? 
differs (see variance 
structure). 
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5 𝑦𝑖 = 𝜇𝑗 + 𝛾𝑙; 
 𝑗 = 𝑡, 𝑐1, 𝑐2, … , 𝑐𝑘; 
 𝑙 = 1, 2, … , 𝑘 
Same as AS 4 𝜇𝑡−𝜇𝑐1
√𝒂′(𝑿′?̂?−1𝑿)−1𝒂
, where 𝒂 is 
the contrast vector, here
(1, −1, 0, … ,0)′
6 𝑦𝑖 = 𝜇𝑗; 
 𝑗 = 𝑡, 𝑐1, 𝑐2, … , 𝑐𝑘 
𝜎2I Same as AS 5 except ?̂? 
differs (see variance 
structure). 
7 𝑦𝑖 = 𝜇𝑗;  𝑗 = 𝑡, 𝑐1 𝜎
2I Same as AS 2 but only 
the current control group 
is used. 
These are not meant to be complete descriptions since the expressions are mostly written out for equal sample sizes 
to avoid including weightings, but should be sufficient to understand how models for the assumption sets (see Table 
1) differ. Also, to avoid making the notation more complicated and to connect better to the other columns, the
expressions in the test column are given using parameters rather than estimates of the parameters (i.e. 𝜎 [population
standard deviation] rather than 𝑠 [sample standard deviation], 𝜇 [population mean] rather than 𝑋 [sample mean]).
The random block (group) effect is notated as 𝛾, with the number of observations in a group represented by 𝑛. The
subscript 𝑖 indexes observations (𝑦), 𝑗 indexes means of treatment (𝜇𝑡) or control groups (𝜇𝑐1, 𝜇𝑐2, …), and there are 𝑘
blocks (groups), indexed with 𝑙. The symbol I represents the identity matrix, the symbol ′ indicates the matrix 
transpose operation.  Other symbols are defined in the table.  Complete formulae can be found in statistics books 
covering linear mixed models, e.g. Milliken & Johnson (2009). 
4. Simulations
To quantify how the various assumptions affect statistical test results, we ran simulated data sets 
(N = 5000) testing for differences between controls and the treatment group through standard 
statistical models in R [lm and t.test in base R (R Core Team, 2013), lme in the nlme package 
(Pinheiro et al., 2013)]. Example R code is given in the Appendix.  We picked a set of 
characteristics that we felt would be typical for biomedical studies involving animals, and similar 
to those from our exemplary data in the extent to which control group means differed from each 
other. We used the same variance for all groups; models allowing for different variances are over-
parameterized. Thus, AS 3 to AS 7 are satisfied since the simulated data were generated with 
varying control group means but the same variance, while AS 1 and 2 are not, since they assume 
that all control group means and variances are the same. However in AS 1, the control is 
considered fixed; the only control information used in the test is a fixed mean (and we used the 
true mean), so simulation results are not affected by the violation. AS 2 is not met because 
control group means are affected by introduced experiment-to-experiment variation. We do not 
give simulation results from AS 2; power for two-sample t-tests can easily be obtained using 
available software.  
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Figure 2. Illustrations of underlying assumptions for statistical models discussed in the 
text and detailed in Table 2 (data simulated). In all models, samples are drawn from a 
normal distribution. In assumption set 1 (AS 1), the control group estimate is considered 
fixed and measured without error. In AS 2, AS 3, AS 6, and AS 7, all groups have the 
same variance; in AS 4 and AS 5 the treatment group has a larger variance than control 
groups. 
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Table 3. Simulation results (N = 5000) giving power to detect a difference between 
treatment and control groups under various assumptions. In this scenario, data were 
simulated from a series of related experiments, one current and others historical, as 

























































3 5 5 4 0.62 0.65 0.65 0.42 0.42 0.34
3 5 5 3 0.61 0.64 0.62 0.41 0.41 0.34
3 5 5 2 0.61 0.60 0.61 0.40 0.40 0.34
3 5 5 1 0.62 0.55 0.54 0.39 0.39 0.34
6 5 5 3 0.61 0.67 0.67 0.56 0.55 0.50
9 5 5 3 0.61 0.71 0.71 0.63 0.63 0.59
12 5 5 3 0.61 0.73 0.72 0.67 0.67 0.65
15 5 5 3 0.61 0.75 0.75 0.71 0.71 0.69
3 10 5 3 0.96 0.80 0.79 0.49 0.49 0.44
3 15 5 3 1.00 0.86 0.86 0.53 0.53 0.50
4 5 5 3 0.60 0.65 0.64 0.47 0.47 0.40
3 5 3 3 0.61 0.59 0.59 0.40 0.40 0.35
The true within-group S.D. was 3 for all groups. For all simulated data sets, historical control means were samples 
from a normal distribution (mean = 10, S.D. = 1), and the current control mean = 10, the current treatment mean = 
14. Models for columns 5–10 are as follows (AS = assumption set): column 5, test against a fixed control mean of 10
(AS 1); column 6, random experiment effect (i.e. experiment 1 had current controls and treated, experiment 2 had
one group of historical controls, experiment 3 had one group of historical controls, etc.), within-group variances all
assumed equal, test (adjusted) current treated mean against the (adjusted) mean of all controls (AS 3); column 7,
same as column 6 except variance of treated group estimated separately (AS 4); column 8, same as column 7 except
test current treated against the current control as a contrast, with historical data included in parameter estimation (AS
5); column 9, same as column 8 except using ANOVA (no random effects, equal variances) (AS 6); column 10, test
current treated against current control (AS 7).
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The simulations were set up with all groups having the same S.D. of 3, but with group 
means differing. Means of historical controls were samples drawn from a normal distribution 
with overall mean 10, S.D. = 1, current control group with mean 10, current treatment group with 
mean 14 (effect size, Cohen’s d = 4/3). We varied the sample sizes of the current treatment and 
control groups, the number of historical control groups included when testing, and the model 
assumptions as described above (see Table 1). Power was near 50%, i.e. significance at α = 0.05 
was detected for about half the simulated data sets, which allowed us easily to see effects of 
changing assumptions. We also ran the same set of simulations, but setting the current treatment 
mean to 10, the same as the control means, to see if the nominal 5% Type I error rate was 
respected by the software when making tests. We do not give results for this. For the most part, as 
expected, approximately 5% of tests were significant, the exception being tests made under AS 4 
above, where values ranged from 6% to 9%. These liberal values suggest to us that variances are 
being slightly under-estimated by the software. This does not affect the conclusions drawn from 
the simulation results that we do report. 
We provide results from the simulations in Table 3. While these results apply directly 
only to the simulated data sets we created, the main conclusions drawn should be generalizable to 
other data sets with similar characteristics, like our exemplary data. Increasing the number of 
total subjects in control groups beyond 18 does little to improve power (first four rows, with four, 
three, two and one historical control groups) under any of the assumptions. Considering historical 
controls fixed (at mean = 10, AS 1) always had high power (column 5), and was surpassed only 
when there were many residual degrees of freedom involved in the statistical tests due to having 
large numbers of historical control subjects available [columns 6 and 7 (AS 3 and 4)]. Allowing 
for unequal variances had little effect on power [column 6 versus 7 (AS 3 and 4), and column 8 
versus 9 (AS 5 and 6); note that the true variances of all groups were the same, so the small 
differences seen are due only to the extra parameter estimated]. Large gains in power can be 
achieved by using historical controls; including historical controls always increased power unless 
a large number of current controls was used, compare column 10 (AS 7) with columns 6–9 (AS 
3–6), for rows 2 and 5–8. Using current controls only [column 10 (AS 7), the usual situation in 
most experiments] had consistently the lowest power, followed by borrowing information only 
for variance estimation [columns 8 and 9 (AS 5 and 6)]. If one can assume that historical controls 
are relatively stable, as could be done for these simulated data, tests had high power [columns 6 
and 7 (AS 3 and 4)]. Increasing the number of current controls (rows 5–8) had the largest impact 
on tests with the weakest assumptions [columns 8–10 (AS 5–6)]. Increasing the sample size of 
the treatment group (rows 9–10) had its largest effect when testing against a fixed control mean 
[column 5 (AS 1)].  
As an example of how many animals could be eliminated by designing an experiment 
using historical controls under the assumption that control means are stable (AS 3 and 4), using 
three current controls and 20 historical controls yielded the same power (0.65) as using 12 current 
and no historical controls, thus one could eliminate nine animals from the current experiment (i.e. 
use a total of eight animals in the current experiment instead of 17) without sacrificing any 
power. Fewer current controls could be eliminated if one only borrows variance information from 
historical controls, but nonetheless some savings are possible. 
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5. When can historical controls be used?
Biomedical experiments are centered on a narrow range of model organisms, often in highly 
controlled settings. In many research laboratories, an experiment is not an isolated event but one 
of a sequence of similar experiments using similar procedures and experimental animals. If 
treatments vary but control conditions stay the same for long series of experiments, there should 
be no controversy using historical controls (Festing & Altman, 2002). In less clear cases, one can 
rely on a combination of familiarity and expertise with the system, perhaps with a small pilot 
study, to make the decision. The key for designing an appropriate control group is that it is 
identical to the treatment group in every way except for the treatment being tested. To the extent 
that historical controls meet this requirement their use―in conjunction with current 
controls―will be justified. Generally, it should be safe to use historical controls from previous 
experiments conducted in the same laboratory using the same species and procedures (Greim et 
al., 2003; Keenan et al., 2009; Hayashi et al., 2011). This recommendation pertains to all the 
various types of controls. 
Consistency between historical and current experimental conditions should be given 
paramount consideration in the decision to incorporate historical controls as part of the 
experimental design. If historical controls are inconsistent with current controls, there is a 
potential for bias and increased type I error. Drift in control values over time, e.g. cure rates 
affected by evolving antibiotic resistance, are a clear case where historical and current controls 
are not consistent. Lack of stability in controls may also reflect changes in study design-related 
parameters such as species/strain, eligibility criteria, route of administration, vehicle, reagents, 
chemical and equipment suppliers, feeding and housing practices, or may be the result of 
sampling error as when the measurements of interest have inherently high variance. Unexplained 
fluctuations in the frequency of spontaneous tumours in control rats have been reported in some 
research facilities (Ando et al., 2008; Kuroiwa et al., 2013). However, what little information is 
available suggests that, when laboratories are well managed, controls are repeatable. For 
example, Hayes et al. (2009) report that the data for 116 control groups (each group with N = 7 
rats) run over several years in the same laboratory were highly repeatable; the rats served as 
vehicle controls for the bone marrow micronucleus test. The authors conclude that ‘no significant 
experimental variability was seen within or between control animals’ (p. 423). This conclusion 
holds despite the fact that the source of the rats changed midway through these years of data 
collection. In this example, all control groups, regardless of origin, were maintained in the same 
laboratory. This differs from clinical studies in which historical controls are obtained from 
sources external to the laboratory conducting the research (Thomas, 2008). The latter use of 
historical controls is controversial because unaccounted differences between laboratories, 
researchers, patients or experimental protocols may render them unsuitable as a reference against 
which current treatment groups can be compared (Diehl & Perry, 1986). Thus, even though it is 
generally agreed that designs using historical controls are highly desirable for ethical and 
economic reasons (e.g. Gehan & Freireich, 1974; Cranberg, 1979), the evidence they provide is 
often considered weaker than, e.g. randomized clinical trials (Doll & Peto, 1980; Pocock, 1983). 
Our proposed use of historical controls is more conservative; it is based on the use of control data 
from previous experiments conducted in the same laboratory rather than on external data sources. 
The decision whether to use historical controls entails a trade-off: the potential introduction of 
some bias in the current study if experimental conditions have changed (i.e. ‘historical bias’) 
versus the reduction of current controls allowed by adding historical information.  
Unfortunately, there is no automatic, foolproof method to help the researcher decide 
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whether or not to include historical controls when only one or two historical control groups are 
available. In fact, to make the determination based on statistics alone would require the large 
sample sizes we advocate eliminating. If many historical control groups are available, we 
recommend using statistical quality-control methods. These methods for determining the 
consistency of a process are well developed and can be used to monitor control animal 
performance over a series of experiments (for examples see Festing & Altman, 2002; Hayes et 
al., 2009); they may already be instituted in well-run laboratories. There are control 
methodologies for both means (X-bar charts) and standard deviations (S-charts) (Wheeler & 
Chambers, 1992). We created standard quality-control charts for the eight control data sets of rat 
haemoglobin concentrations and found that three of the groups (A.c, D.c, G.t; see Fig. 1) 
exceeded the X-bar chart confidence limits (i.e. the assumption of a common mean is not 
supported). However, none exceeded the S-chart confidence limits (i.e. assuming a common 
standard deviation or variance is reasonable). These data would have satisfied AS 6, and also AS 
3 if the kind of variation seen in the means was typical experiment-to-experiment variability, i.e. 
could be modeled as a random effect, or had additional information explaining why these control 
groups differed, e.g. due to different age or sex compositions. 
What assumptions are applicable in a particular case depends largely on the type of 
historical controls available. If the experimental protocol remains unchanged throughout the 
period when historical control data were collected and there is little variation among controls over 
time, one may assume that historical controls have a fixed mean (and variance) and use them to 
estimate parameters relating to the current experiment. With less-stable historical controls the 
researcher has to decide whether it makes sense to incorporate information from their mean 
and/or variance. Assuming that historical control groups can be used to estimate a common 
control mean and variance allows for a greater reduction in animals than assuming that controls 
can only be used to estimate a common variance.  
Randomization and blinding are essential aspects of experimental design, but their 
application to historical controls is not straightforward. Blinding may be hard to implement but 
randomization should not be an issue in most cases. Subjects should be randomly allocated to 
current control and treatment groups, and suitably randomized in the experiments from which the 
historical controls are taken, but randomizing across experiments has been constrained, i.e. each 
experiment can be considered a constraint on randomization. This is the classic situation 
producing a randomized block design. The mixed models take that into account by considering 
each experiment as a block (see Table 2).  
6. Determining sample sizes when using historical controls
Currently, there is no off-the-shelf software for determining how to substitute historical controls 
for current controls for many of our assumption sets. We suggest determining sample size using 
the usual tools for current controls only (AS 7), then determine how many historical controls can 
be substituted for each current control using simulations or ‘rules of thumb’, which will depend 
on which AS is used. For AS 2, each historical control is equivalent to one current control, i.e. 
there is a 1:1 substitution. AS 6 uses a contrast from a linear model, so sample sizes can be 
calculated using standard statistical software that estimates power, as long as contrasts can be 
specified. Based on our simulations for AS 3, that is, based on characteristics we dictated when 
creating data, substitution was conservatively 2:1 (historical:current). This can be seen in Table 3 
by comparing columns 6 and 10 where power is approximately the same. In one case, the ratio is 
10:6 (historical:current), in another it is 15:9 (this is after adjusting for the three current controls 
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under AS 3). This result is only loosely generalizable: a different set of characteristics would 
yield different ratios. AS 3–6 are built on mixed models, where assessing power is not trivial 
since models can vary in many dimensions; simulation currently provides the most accurate 
estimate of power under different allocations of controls (Johnson et al., 2015). Software for 
calculating power and sample size for experiments like these is readily available for AS 1, 2, and 
7. It can also be found for AS 3 (blocks may be labeled ‘clusters’), for example, in the software
MLPowSim (which can write R scripts or call MLwiN for estimation; downloadable from
http://www.bristol.ac.uk/cmm/software/mlpowsim/), OD (hlm.soft.net/od/), and GLIMMPSE
(glimpse.samplesizeshop.org, which uses the general linear multivariate model parameterization).
Another on-line tool, SMEEACT (research.mdacc.tmc.edu/SmeeactWeb/Default.aspx) uses a
Bayesian approach and can provide the weight that should be given to historical controls, based
on their stability, for a set of anticipated or realized data. We do not know of software packages
that can be used off-the-shelf for these purposes for AS 4, 5, 6 and 8; see Appendix for the R
code.
We do not advocate borrowing information from historical controls for analyses using 
proportion data, e.g. proportion that improved after receiving a treatment, unless one can make 
the assumption that control proportions are constant over time. This is the basic strategy taken by 
Korn & Freidlin (2006) and others dealing with proportion data (e.g. Yanagawa & Hoel, 1985; 
Hayashi et al., 1989; Ryan, 1993; Yoshimura & Matsumoto, 1994). The reason for this lies in the 
difference between the normal distribution and other members of the exponential family of 
distributions (e.g. binomial, Poisson). The normal distribution has the property that the mean and 
variance are independent. Because of this property, if one assumes that within-control group 
variances are relatively constant, it makes sense to estimate this variance from a large number of 
observations: by borrowing information from historical data we increase the number of 
observations. However, the binomial and Poisson distribution are one-parameter distributions, 
with a single parameter and the known sample size determining both the mean and variance. 
Unless the control proportion rate is stable, borrowing information from historical controls in a 
proportion data set which is assumed to be generated by a binomial process would not increase 
the precision of the current control proportion since there is no independent variance estimate. 
We should use historical control data to assess whether variability over time in controls is greater 
than that expected from sampling error alone (i.e. resulting in over-dispersion) as a means of 
monitoring stability in laboratory conditions. Models for binomial data that include historical 
control groups as random effects (Maringwa et al., 2007) can improve the estimate for the true 
response proportion of controls (this is in the generalized linear mixed-models framework). These 
models can also allow for over-dispersion, a common feature of binomial data, and the additional 
historical controls will improve the estimate of over-dispersion.  
7. Recommendations
The three Rs of replacement, reduction and refinement originally proposed by Russell & Burch 
(1959) provide a widely accepted framework for conducting animal experiments. One area where 
progress has been somewhat limited is in the reduction of the number of animals included in an 
experiment. Reduction entails seeking ways of obtaining comparable levels of information from 
the use of fewer experimental animals, or of obtaining more information from a given number of 
animals (Festing et al., 1998). Compared to refinement and replacement, which often require 
technical advances, implementing reduction strategies has an immediate impact on animal 
welfare. Reducing the number of animals will also result in a reduction of the resources and 
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workload required to run an experiment. Therefore, for both ethical and economic reasons, 
experiments should be designed such that they use the minimum number of animals necessary to 
achieve meaningful scientific results. Reduction of the number of current controls provides a 
relatively straightforward means to this end. 
We are not advocating that researchers eliminate or arbitrarily reduce control groups. 
Quite to the contrary, our aim here is to convince the reader that control groups deserve far 
greater attention than is current practice. A thorough understanding of the role of controls is 
crucial to conducting research that is both effective and ethically acceptable. Experiments in 
which controls are subjected to painful or stressful procedures with a highly predictable endpoint 
are relatively common and should be given special consideration. Recent surveys have shown 
that much animal experimentation is grossly underpowered (e.g. Button et al., 2013), and as a 
consequence a typical researcher may be hesitant to reduce the number of subjects used in an 
experiment. But if the aim of the controls is simply to guarantee that experimental procedures 
work adequately, a reduction may be fully justified on ethical grounds. 
Under conditions discussed above, the power loss resulting from a reduction in the 
number of current controls can be offset by borrowing information from historical controls. This 
allows the researcher to minimize the amount of suffering while at the same time preserving 
statistical power. Our simulations show that there is always a benefit to including historical 
controls as fewer current controls are needed to achieve the desired power. Interestingly, the 
largest gains in power (up to 50%) in our simulations are obtained when the number of animals in 
the treatment group is increased and historical controls are used. Thus, a researcher that has 
discretion over the number of subjects allocated to different groups may achieve a more powerful 
design by incorporating historical controls and relocating subjects from the current control to the 
treatment group.  
The current discussion of the use of historical controls is targeted to biomedical 
experimentation, which arguably accounts for the largest number of procedures involving 
animals. However, the focus can be fruitfully broadened to other areas of research using animals. 
Circumstances will likely vary among different disciplines but drawing on historical control data 
will generally allow a reduction of the number of animals allocated to current control groups and 
therefore contribute to the goal of saving time, resources and animal lives. Additional details and 
a discussion of other aspects of the use of controls in biomedical experiments is given in Kramer 
and Font (2017) 
8. Summary
Control groups are included in most experiments, and they offer a relatively untapped potential to 
reduce sample size without sacrificing statistical power. Controls can be categorized as current or 
historical. Historical controls are controls from past experiments that used the same protocols as 
the current experiment.  Historical information is used to design most experiments (i.e. to 
calculate sample sizes based on previously observed variabilities and effect sizes). However, use 
of historical controls is restricted to a few areas of biomedical research and is regarded with 
skepticism by many researchers who are unaware of their potential usefulness or do not know 
how to incorporate them into their experimental designs.  We show, using both a real data 
example and computer simulations, how to use historical controls under various sets of 
assumptions. In general, use of historical controls reduces the number of current controls 
necessary in an experiment and improves the researcher’s ability to detect treatment effects.  
Borrowing information from historical controls entails a tradeoff between the potential 
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introduction of bias (if historical controls do not adequately reflect current experimental 
conditions) and the reduction of current control subjects. Consistency between historical and 
current experimental conditions should be the most important consideration in the decision to 
incorporate historical controls as part of the experimental design. When similar experiments are 
performed repeatedly in the same laboratory, using the same standard research and husbandry 
protocols and the same animals (e.g. a single strain and sex of mice), there will often be scope for 
the incorporation of historical controls.  Understanding the role of controls is crucial to 
conducting research that is both effective and ethically acceptable. An efficient use of controls 
can reduce the number of animals required and maximize the information obtained per 
experiment. Given the sheer number of animals that are routinely used as part of control groups, 
the procedures we outline can make a substantial contribution towards the goal of reducing the 
number of animals used in biomedical research.  
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APPENDIX 
# This R code generates the results given in Table 3.  Comments in blue. 
# It can also be used to estimate power for the various Assumption Sets. 
# For that use, values in mpv will need to be edited (to change sample sizes 
# and the number of historical control groups, see line 27).  Variables defining 
# the means and standard deviations will also need to be changed, e.g. mc1, mt1 
# for means and the hard coded standard deviations (lines 42, 43, 46) 
# Matt Kramer:  matt.kramer@ars.usda.gov 
require (nlme) 
n3 <- 5000  # number of simulations for each AS (Assumption Set) 
# matrix below specifies the parameters for each AS (see lines 27-30) 
mpv <- matrix (c ( 3,  5, 5, 4,  # effect of number of groups of historical controls 
3,  5, 5, 3,  # (col 4) 
3,  5, 5, 2, 
3,  5, 5, 1, 
6,  5, 5, 3,   
9,  5, 5, 3,  # effect of number of current controls (col 1) 
12,  5, 5, 3, 
15,  5 ,5, 3, 
3, 10, 5, 3, 
3, 15, 5, 3, 
4,  5, 5, 3, 
3,  5, 3, 3), 
nrow=4) 
mpv <- t(mpv) 
for (j in 1:nrow(mpv)) { 
n1c <- mpv[j,1]  # number current controls 
n1t <- mpv[j,2]  # number current treatments 
n2 <- mpv[j,3]   # number of historical controls/group 
nhc <- mpv[j,4]  # number of historical control groups 
# create vectors to hold p-values for AS's 
p0 <- numeric(n3)  # test against a known control mean 
p1 <- numeric(n3)  # p1 - p5: tests for other AS's 
p2 <- numeric(n3) 
p3 <- numeric(n3) 
p4 <- numeric(n3) 
p5 <- numeric(n3) 
mc1 <- 10 # mean of control groups 
mt1 <- 14 # mean of treatment group 
for (i in 1:n3) {  # start the n3 simulations 
# generate normally distributed data for the historic control groups 
m1 <- rnorm(nhc,mc1,1)  # generate means for the control groups 
prior2 <- rnorm(n2,m1[1],3) # first historic control group 
if (nhc > 1) { 
for (j in 2:nhc) { 
prior2 <- c(prior2,rnorm(n2,m1[j],3)) # additional historic control groups 
} 
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exp1a <- rep(letters[2:(nhc + 1)], each=n2)  # start from b 
current1a <- c(rnorm(n1t,mt1,3), rnorm(n1c,mc1,3))  # generate current treatments,
 # controls 
exp2a <- rep("a", n1t + n1c) 
 exp2b <- c(rep("A", n1t), rep("C", nhc*n2 + n1c))  # use A for treatment to make 
# it first 
all1a <- data.frame(exp=c(exp2a,exp1a), treat=exp2b, y=c(current1a, prior2)) 
# create data.frame 
all1a$exp.treat <- factor(paste(all1a$exp, all1a$treat, sep="."))  
# create factor levels 
all1b <- groupedData (y ~ exp.treat | exp, data=all1a)   # make a grouped data set 
# contrast treatment vs all controls, allow for experiment effect, variances equal 
fit1a <- lme (y ~ treat, random = ~ 1 | exp, data=all1b)  
tl <- all1a == "a" 
# just use current data, variances equal 
fit1b <- lm (y ~ treat, data=all1a, subset=tl) 
t1 <- t.test (current1a[1:n1t], alternative="two.sided", mu=mc1)  # against fixed  
# contrast treatment with all controls, allow for unequal variances  
fit1c <- lme (y ~ treat, random = ~ 1 | exp, weights =  varIdent (form =  ~ 1 | 
 treat), data=all1b) 
# contrast treatment with current control, allow for unequal variances  
fit1d <- lme (y ~ exp.treat, random = ~ 1 | exp, weights =  varIdent (form =  ~ 1 
| treat), data=all1b) 
# contrast current C & T using all data, no random effects 
fit1f <- lm (y ~ exp.treat, data=all1a)  
p0[i] <- t1$p.value # AS1 
p1[i] <- summary(fit1a)$tTable [2,5] # AS3  
p2[i] <- summary(fit1b)$coefficients [2,4] # AS7 
p3[i] <- summary(fit1c)$tTable [2,5] # AS4
p4[i] <- summary(fit1d)$tTable [2,5] # AS5
p5[i] <- summary(fit1f)$coefficients [2,4] # AS6 
}  # end: simulations 
# this is the order in Table 2 of publication 
cat (sprintf ("%3s %3s %3s %3s   %4.2f %4.2f %4.2f %4.2f %4.2f %4.2f\n", 
n1c, n1t, n2, nhc, 
sum(p0 < 0.05)/n3, 
sum(p1 < 0.05)/n3, 
sum(p3 < 0.05)/n3, 
sum(p4 < 0.05)/n3, 
sum(p5 < 0.05)/n3, 
sum(p2 < 0.05)/n3) 
) 
}  # end: various combinations of current treatment, current control, historical controls 
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